Global Type 2 Diabetes Medication Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Type 2 Diabetes Medication Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
This Report focus on medications for type 2 diabetes.
People with type 2 diabetes are often given medications including insulin to help manage their blood glucose levels. Most of these medications are in the form of tablets, but some are given by injection. Tablets or injections are intended to be used in conjunction with healthy eating and regular physical activity, not as a substitute.
Type 2 Diabetes Medication report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Type 2 Diabetes Medication market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Type 2 Diabetes Medication industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Type 2 Diabetes Medication key companies include AstraZeneca, Novartis, Novo Nordisk, Johnson & Johnson, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Merck and Sanofi, etc. AstraZeneca, Novartis, Novo Nordisk are top 3 players and held % share in total in 2022.
Type 2 Diabetes Medication can be divided into Biguanides, Sulphonylureas, Thiazolidinediones and Alpha-glucosidase Inhibitors, etc. Biguanides is the mainstream product in the market, accounting for % share globally in 2022.
Type 2 Diabetes Medication is widely used in various fields, such as Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, etc. Hospital Pharmacies provides greatest supports to the Type 2 Diabetes Medication industry development. In 2022, global % share of Type 2 Diabetes Medication went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Type 2 Diabetes Medication market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
AstraZeneca
Novartis
Novo Nordisk
Johnson & Johnson
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
Merck
Sanofi
Pfizer
Astellas Pharma
Daiichi Sankyo
Biocon
Glenmark
Bayer AG
Takeda
Sun pharma
Segment by Type
Biguanides
Sulphonylureas
Thiazolidinediones
Alpha-glucosidase Inhibitors
DPP-4 Inhibitors
GLP-1 Receptor Agonists
SGLT-2 Inhibitors
Insulins
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Type 2 Diabetes Medication market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Type 2 Diabetes Medication introduction, etc. Type 2 Diabetes Medication Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Type 2 Diabetes Medication market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
People with type 2 diabetes are often given medications including insulin to help manage their blood glucose levels. Most of these medications are in the form of tablets, but some are given by injection. Tablets or injections are intended to be used in conjunction with healthy eating and regular physical activity, not as a substitute.
Type 2 Diabetes Medication report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Type 2 Diabetes Medication market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Type 2 Diabetes Medication industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Type 2 Diabetes Medication key companies include AstraZeneca, Novartis, Novo Nordisk, Johnson & Johnson, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Merck and Sanofi, etc. AstraZeneca, Novartis, Novo Nordisk are top 3 players and held % share in total in 2022.
Type 2 Diabetes Medication can be divided into Biguanides, Sulphonylureas, Thiazolidinediones and Alpha-glucosidase Inhibitors, etc. Biguanides is the mainstream product in the market, accounting for % share globally in 2022.
Type 2 Diabetes Medication is widely used in various fields, such as Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, etc. Hospital Pharmacies provides greatest supports to the Type 2 Diabetes Medication industry development. In 2022, global % share of Type 2 Diabetes Medication went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Type 2 Diabetes Medication market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
AstraZeneca
Novartis
Novo Nordisk
Johnson & Johnson
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
Merck
Sanofi
Pfizer
Astellas Pharma
Daiichi Sankyo
Biocon
Glenmark
Bayer AG
Takeda
Sun pharma
Segment by Type
Biguanides
Sulphonylureas
Thiazolidinediones
Alpha-glucosidase Inhibitors
DPP-4 Inhibitors
GLP-1 Receptor Agonists
SGLT-2 Inhibitors
Insulins
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Type 2 Diabetes Medication market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Type 2 Diabetes Medication introduction, etc. Type 2 Diabetes Medication Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Type 2 Diabetes Medication market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices